“Research is certainly at a good point because in the last 20 years multiple sclerosis is one of the diseases for which the best successes and, above all, answers have been obtained, but there is still a lot to do. What is being done today it is trying to understand not so much the moment of diagnosis but the prodromal moment, that is, what happens before the diagnosis. We can anticipate the diagnosis, we can start therapies even earlier and this would mean even more not reaching disability”. This was said by Mario Alberto Battaglia, president of Fism (the Foundation of Aism – Italian Multiple Sclerosis Association), on the occasion of the National Multiple Sclerosis Week of Aism 2024, dedicated to information and awareness on the disease.
“Research is also working hard on a theme that is fundamental: we can reconstruct the damage – underlines Battaglia – we can reconstruct the myelin, we can find alternatives not only with rehabilitation which increases the plasticity of the nervous system, but above all by rebuilding with the adequate cells the damage”.
“A lot is also being done on this with human experimentation, with drug experimentation, and many experiments and research are financed by our foundation. And it is essential to continue on this path – he remarks – because the answer must come both for the people who will no longer have to get sick tomorrow, both for people who today have MS recently and do not want a progression of disability, and those who have multiple disabilities want concrete answers for a better quality of life”.
“Only by inserting research priorities within a global strategy, and valorising the contribution of patients, can we respond to the needs of people with multiple sclerosis. In doing so we have set ourselves three directions. The first aims to block multiple sclerosis, the progression of symptoms and disability, finding new treatments that are still missing. The second aims to recover function: finding strategies to repair myelin, making rehabilitation more and more effective, improving people’s quality of life. ambition to put an end to MS once and for all, which means reducing risk factors to zero and arriving at a world in which there is no longer any diagnosis of multiple sclerosis”. Thus Mario Alberto Battaglia, president of Fism (Foundation of the Italian Multiple Sclerosis Association), at the opening of the annual Fism Congress, starting today in Rome at the Hotel Villa Pamphili, until May 30th, entitled ‘Brain health: rethink the diagnosis of multiple sclerosis and related pathologies’.
There are 188 projects underway, in the period 2022-2024, supported by Fism (84 to block MS, 74 to restore function, 23 for primary prevention and 7 to strengthen research infrastructures) for a total investment of over 56 million euros. To these – reports a note – another 5 million euros will be added with the financing of the Fism 2024 tender, obtained largely thanks to the citizens’ 5xthousand contribution. Fism and its researchers are part of an international network and in 2023, together with the associations of Australia, Canada, Denmark, France, Germany, Spain, the United Kingdom, the United States and the International SM Federation, they committed to a global research strategy .
#Battaglia #Fism #successes #achieved #multiple #sclerosis #years
